Almirall SA 2015 AR2
The report highlights Almirall's strategic transition in 2015 to become a leading specialty pharmaceutical company focused on dermatology. Key achievements include the acquisition of Poli Group and investments in Suneva Medical and ThermiGen to enter the aesthetics market. Financially, the company achieved total revenues of €769 million, with dermatology sales growing by 15.9% to represent 43.1% of net sales. On the environmental front, Almirall reduced its greenhouse gas emissions by 32% over the 2012–2015 period and achieved a 5.14% reduction in electricity consumption in 2015. Additionally, the company recorded historically low workplace accident rates, with a 69% reduction in Spain.
Company: Almirall SA
Sector: Manufacturing
Country: Spain
Year: 2015
Type: AR2
Pages: 82
Back to company
Almirall SA
Annual Report
The report highlights Almirall's strategic transition in 2015 to become a leading specialty pharmaceutical company focused on dermatology. Key achievements include the acquisition of Poli Group and investments in Suneva Medical and ThermiGen to enter the aesthetics market. Financially, the company achieved total revenues of €769 million, with dermatology sales growing by 15.9% to represent 43.1% of net sales. On the environmental front, Almirall reduced its greenhouse gas emissions by 32% over the 2012–2015 period and achieved a 5.14% reduction in electricity consumption in 2015. Additionally, the company recorded historically low workplace accident rates, with a 69% reduction in Spain.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2015
Reporting Period
2015
Fiscal Year
2015
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Assurance
Assurance Provider
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Total Waste
Employees